Fundraising Fox

Nohla Therapeutics

Seattle, US · Founded 2015 · Delaware corporation

Biotech

Founders & leadership

DS
Darren ScottiExecutive
BS
Benjamin Scot BergoExecutive

Board

LG
Lawrence GozlanBoard director
ID
Ian David BrownBoard director

Reported raises · per SEC filings

Form D private placements

$79.4M disclosed across 3 rounds · 2015–2018

▶$45MraisedMay 2018 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven GillisDirector
  • Jim JohnsonExecutive Officer
  • Lawrence GozlanDirector
  • Michael SistenichDirector
  • Brian DanielsDirector
  • Gary ChristiansonExecutive Officer
  • Colleen DelaneyExecutive Officer
  • Kathleen FanningExecutive Officer, Director
Offering amount
$58.4M
Amount sold
$45M
First sale
May 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32.4MraisedNov 2017 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence GozlanDirector
  • Kathleen FanningExecutive Officer, Director
  • Michael SistenichDirector
  • Steven GillisDirector
  • Brian DanielsDirector
Offering amount
$41.5M
Amount sold
$32.4M
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedDec 2015 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lawrence GozlanDirector
  • Ian David BrownDirector
  • Darren ScottiExecutive Officer
  • Benjamin Scot BergoExecutive Officer, Director, Promoter
Offering amount
$2M
Amount sold
$2M
First sale
Dec 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Nohla Therapeutics raises another $11M to support leukemia treatment trials – GeekWiregeekwire.com · Jul 2018Nohla Therapeutics Announces Second Closing of $56 Million Series B FinancingAdditional $11 Million Raised from Three New International Investors and One Existing Investor - BioSpacebiospace.com · Jul 2018Nohla Therapeutics raises $45M, gets new HQ as it moves novel leukemia treatment closer to market - Washington Research Foundationwrfseattle.org · May 2018Fred Hutch spinout Nohla Therapeutics raises $43.5M to develop therapy for Leukemia – GeekWiregeekwire.com · Dec 2016Nohla Therapeutics raises $43.5M to develop universal donor cellular therapies - MedCity Newsmedcitynews.com · Nov 2016NOHLA THERAPEUTICS LAUNCHES WITH MAJOR US CANCER RESEARCH INSTITUTE DEAL, SUBSTANTIAL INVESTMENT ROUND, AND KEY APPOINTMENTS | Fierce Biotechfiercebiotech.com · Dec 2015

Frequently asked questions

How much funding has Nohla Therapeutics raised?
Nohla Therapeutics has disclosed $79.4M raised across 3 rounds.
Where is Nohla Therapeutics headquartered?
Nohla Therapeutics is headquartered in Seattle, US.